Den europeiske union - estisk - EMA (European Medicines Agency)

eisai gmbh - rufinamide - epilepsia - antiepileptics, - inovelon on näidustatud adjunctive ravi ravi krambid seotud lennox gastaut sündroomiga patsientidel, 4-aastased ja vanemad.

Estland - estisk - Ravimiamet

g.l. pharma gmbh - nebivolool - tablett - 5mg 14tk; 5mg 30tk; 5mg 56tk; 5mg 50tk; 5mg 7tk; 5mg 100tk; 5mg 28tk

Estland - estisk - Ravimiamet

intervet international b.v. - lindude nakkava bronhiidi viirusvaktsiin+newcastle'i tõve viirus-/paramüksoviirusvaktsiin - lüofilisaat okulonasaalsuspensiooni valmistamiseks/joogivees manustamiseks - 1000eid50+1000000eld50 1annus 2500annus 6tk; 1000eid50+1000000eld50 1annus 1000annus 1tk; 1000eid50+1000000eld50 1annus 5000annus 6tk; 1000eid50+1000000eld50 1annus 1000annus 12tk; 1000eid50+1000000eld50 1annus 1000annus 6tk; 1000eid50+1000000eld50 1annus 10000annus 12tk; 1000eid50+1000000eld50 1annus 5000annus 12tk; 1000eid50+1000000eld50 1annus 1000annus 10tk; 1000eid50+1000000eld50 1annus 10000annus 6tk; 1000eid50+1000000eld50 1annus 2500annus 10tk

Estland - estisk - Ravimiamet

uab aveco"" - viirpuuvili - suukaudsed tilgad, lahus - 1ml 1ml 25ml 1tk; 1ml 1ml 80ml 1tk

Estland - estisk - Ravimiamet

synthon b.v. - pramipeksool - tablett - 0,18mg 30tk; 0,18mg 100tk

Estland - estisk - Ravimiamet

intervet international b.v. - lindude nakkava bronhiidi viirusvaktsiin - lüofilisaat okulonasaalsuspensiooni valmistamiseks/joogivees manustamiseks - 3log10 eid50 1annus 5000annus 10tk; 3log10 eid50 1annus 10000annus 12tk; 3log10 eid50 1annus 5000annus 12tk; 3log10 eid50 1annus 1000annus 10tk; 3log10 eid50 1annus 1000annus 12tk

Estland - estisk - Ravimiamet

synthon b.v. - pramipeksool - tablett - 0,7mg 100tk

Estland - estisk - Ravimiamet

synthon b.v. - pramipeksool - tablett - 0,088mg 100tk

Den europeiske union - estisk - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - tsüstiline fibroos - muud hingamisteede tooted - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Den europeiske union - estisk - EMA (European Medicines Agency)

vmd n.v. - tulatromütsiin - antibacterials for systemic use, macrolides - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. haiguse esinemine karjas tuleb kindlaks määrata enne metafülaktilist ravi. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. haiguse esinemine karjas tuleb kindlaks määrata enne metafülaktilist ravi. the product should only be used if pigs are expected to develop the disease within 2–3 days. lambad: nakkusliku pododermatiidi (suu mädanemine) varajase staadiumi ravi, mis on seotud virulentse dichelobacter nodosus'ega ja vajab süsteemset ravi.